Company Filing History:
Years Active: 2015
Title: **Innovative Contributions of Inventor Wee Han Ang in Cancer Treatment**
Introduction
Wee Han Ang is an accomplished inventor based in Ecublens, Switzerland, who has made significant strides in the field of cancer treatment through his innovative research. With one patented invention, he stands out for his contributions to enhancing resistance management in cancer therapies.
Latest Patents
Wee Han Ang holds a patent for "Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis." This invention focuses on organometallic compounds that play a crucial role in combating metastasis, which is the spread of cancer to other parts of the body. The compounds developed in his patent feature a ligand that is covalently bound to a bioactive compound, specifically designed to act as an inhibitor of resistance pathways. Notably, these organometallic compounds are categorized as half-sandwich ('piano-stool') compounds, providing a diverse range in terms of the bioactive compound and the nature of the ligand associated with the central transition metal.
Career Highlights
Wee Han Ang is affiliated with the École Polytechnique Fédérale de Lausanne (EPFL), a prestigious institution recognized for its cutting-edge research and innovation in science and technology. His tenure at EPFL has allowed him to engage in impactful research, culminating in his patent that could potentially transform approaches in cancer treatment.
Collaborations
In his endeavors, Wee Han Ang has collaborated with fellow researcher Paul Joseph Dyson. Their partnership has facilitated shared insights and advancements in the research surrounding organometallic compounds, ultimately enhancing the efficacy of cancer therapies.
Conclusion
Wee Han Ang's work exemplifies the intersection of innovation and scientific research, particularly in the critical field of cancer treatment. His patented organometallic compounds pave the way for new therapeutic approaches that may significantly reduce resistance in cancer therapies, highlighting his status as a notable inventor in the realm of medical innovations.